Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polo-like kinase 2 (PLK2) is a serine/threonine-protein kinase and a member of the polo-like kinase family, which plays critical roles in cell cycle regulation, cell division, and various cellular processes. It is involved in mitotic centriole replication, meiotic chromatin pairing, synapsis, and crossing-over, cell differentiation, ontogenesis, stress response, tumorigenesis, neurodegenerative diseases, inflammation, and injury responses. PLK2's dysregulation is linked to tumorigenesis and neurodegenerative diseases. Modulating PLK2 activity may hold therapeutic potential for cancer and neurodegenerative diseases.
Kinase inhibition (potential)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polo-like kinase 2 (PLK2).